The stock of Novadaq Technologies Inc. (NASDAQ:NVDQ) hit a new 52-week low and has $6.99 target or 14.00% below today’s $8.13 share price. The 7 months bearish chart indicates high risk for the $468.71M company. The 1-year low was reported on Nov, 16 by Barchart.com. If the $6.99 price target is reached, the company will be worth $65.62M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 38,530 shares traded hands. Novadaq Technologies Inc. (NASDAQ:NVDQ) has declined 30.85% since April 14, 2016 and is downtrending. It has underperformed by 35.53% the S&P500.
Novadaq Technologies Inc. (NASDAQ:NVDQ) Ratings Coverage
Out of 4 analysts covering Novadaq Technologies Inc (NASDAQ:NVDQ), 4 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Novadaq Technologies Inc has been the topic of 6 analyst reports since October 7, 2015 according to StockzIntelligence Inc. The company was upgraded on Thursday, October 29 by First Analysis. The rating was initiated by Wedbush on Wednesday, October 7 with “Outperform”. JMP Securities initiated the shares of NVDQ in a report on Wednesday, January 6 with “Mkt Outperform” rating.
According to Zacks Investment Research, “Novadaq Technologies Inc. develops, manufactures and markets real-time fluorescence imaging products for use in the operating room and other clinical settings. The company’s key markets include plastic reconstructive, gastrointestinal, cardiac and general surgery. It provides SPY imaging systems which enables surgeons to the visualize blood flow in vessels, co-joined vessels and micro-vessels. Novadaq Technologies Inc. is headquartered in Mississauga, Canada.”
Another recent and important Novadaq Technologies Inc. (NASDAQ:NVDQ) news was published by Globenewswire.com which published an article titled: “NOVADAQ and Arthrex Announce Co-Marketing Agreement for PINPOINT Fluorescence …” on October 01, 2015.
NVDQ Company Profile
Novadaq Technologies Inc., incorporated on April 14, 2000, is a medical device company. The Firm primarily develops, makes and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company’s segment is medical devices. The Company’s SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.